Reduced tyrosine phosphorylation of P210BCR-ABL and lack of STAT5 activation in BCR-ABL-transduced IL-3-/- primitive hematopoietic cells.

被引：0
|
作者：
Jiang, XY [1 ]
Yip, C [1 ]
Eisterer, W [1 ]
Eaves, A [1 ]
Eaves, C [1 ]
机构：
[1] British Columbia Canc Agcy, Terry Fox Lab, Vancouver, BC V5Z 1L3, Canada
来源：
BLOOD | 2000年 / 96卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
395
引用
收藏
页码：92A / 92A
页数：1
相关论文
共 50 条
  • [41] The pyrido[2,3-d]pyrimidine derivative PD180970 inhibits p210Bcr-Abl tyrosine kinase and induces apoptosis of K562 leukemic cells
    Dorsey, JF
    Jove, R
    Kraker, AJ
    Wu, J
    CANCER RESEARCH, 2000, 60 (12) : 3127 - 3131
  • [42] Primitive interleukin 3 null hematopoietic cells transduced with BCR-ABL show accelerated loss after culture of factor-independence in vitro and leukemogenic activity in vivo
    Jiang, XY
    Ng, E
    Yip, C
    Eisterer, W
    Chalandon, Y
    Stuible, M
    Eaves, A
    Eaves, CJ
    BLOOD, 2002, 100 (10) : 3731 - 3740
  • [43] Functional cooperation among Ras, STAT5, and phosphatidylinositol 3-kinase is required for full oncogenic activities of BCR/ABL in K562 cells
    Sonoyama, J
    Matsumura, I
    Ezoe, S
    Satoh, Y
    Zhang, X
    Kataoka, Y
    Takai, E
    Mizuki, M
    Machii, T
    Wakao, H
    Kanakura, Y
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (10) : 8076 - 8082
  • [44] Tyrosine phosphorylation of p95(Vav) in myeloid cells is regulated by GM-CSF, IL-3 and steel factor and is constitutively increased by p210(BCR/ABL) (vol 14, pg 257, 1995)
    Matsuguchi, T
    Inhorn, R
    Carlesso, N
    Xu, G
    Druker, B
    Griffin, J
    EMBO JOURNAL, 1996, 15 (04): : 954 - 954
  • [45] P95VAV IS TYROSINE-PHOSPHORYLATED BY GM-CSF, IL3, STEEL FACTOR AND P210BCR/ABL, AND IS ASSOCIATED WITH JAK KINASES IN MYELOID CELLS
    MATSUGUCHI, T
    INHORN, RC
    CARLESSO, N
    GRIFFIN, JD
    BLOOD, 1994, 84 (10) : A369 - A369
  • [46] Phosphorylation levels of BCR-ABL, CrkL, AKT and STAT5 in imatinib-resistant chronic myeloid leukemia cells implicate alternative pathway usage as a survival strategy
    Jilani, Iman
    Kantarjian, Hagop
    Gorre, Mercedes
    Cortes, Jorge
    Ottmann, Oliver
    Bhalla, Kapil
    Giles, Francis J.
    Albitar, Maher
    LEUKEMIA RESEARCH, 2008, 32 (04) : 643 - 649
  • [47] BCR-ABL p210 and p190 induce constitutive activation of STAT 5, 1 and 6 in human and murine factor-dependent cell lines
    Fourt, ID
    Ahmed, A
    Bennardo, T
    Issaad, C
    Varet, B
    Vainchenker, W
    Turhan, AG
    BRITISH JOURNAL OF HAEMATOLOGY, 1996, 93 : 745 - 745
  • [48] BCR/ABL→STAT5 pathway stimulates helix-loop-helix Id-1 protein to enhance the MMP9 -: Dependent invasiveness of leukemia cells.
    Nieborowska-Skorska, M
    Hoser, G
    Malecki, M
    Wasik, M
    Skorski, T
    BLOOD, 2004, 104 (11) : 807A - 807A
  • [49] An in vivo and in vitro comparison of the effects of b2-a2 and b3-a2 p210BCR-ABL splice variants on murine 32D cells
    Guinn, BA
    Evely, RS
    Walsh, V
    Gilkes, AF
    Burnett, AK
    Mills, KI
    LEUKEMIA & LYMPHOMA, 2000, 37 (3-4) : 393 - 404
  • [50] P210 Bcr-Abl interacts with the interleukin 3 receptor beta(c) subunit and constitutively induces its tyrosine phosphorylation (vol 56, pg 3426, 1996)
    WilsonRawls, J
    Xie, SH
    Liu, JX
    Laneuville, P
    Arlinghaus, RB
    CANCER RESEARCH, 1996, 56 (19) : 4549 - 4549
12345